Filter by:

www.msac.gov.au

/var/www/disclogs/web/web/showDomain.php (line 14)
  • reset($query->fetchAll(PDO::FETCH_ASSOC))
    9
    array
    • domain_name
      www.msac.gov.au
      15
      string
    • second_level_domain_name
      msac.gov.au
      11
      string
    • whois
      null
      null
    • dns
      {"CNAME": ["www.health.gov.au."], "DNAME": ["health.gov.au."]}
      stringjsonobject
    • ip_whois
      null
      null
    • active
      true
      boolean
    • data_created_at
      2018-04-28 13:41:26.482276+00
      -6m 4w
      stringdatetime
    • data_updated_at
      2018-05-15 10:13:15.990783+00
      -6m 2w
      stringdatetime
    • https
      false
      5
      string
titlepathsize_bytesword_countload_time
/internet/msac/publishing.nsf/Content/0BD63667C984FEEACA25801000123AD8/$File/InvestigativeTechnicalGuidelines-December-2016-Version-3.0.pdf 3293206 85555 0.883837615
MSAC - 1146.3 - Capsule Endoscopy for the Diagnosis of Suspected Small Bowel Crohn Disease (Resubmission) /internet/msac/publishing.nsf/Content/1146.3-Public 24870 799 0.350286019
MSAC - 1196 - Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression. /internet/msac/publishing.nsf/Content/1196-public 23853 515 0.54534624
MSAC - 1342.4 - Oncotype DX� breast cancer assay to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit (Resubmission) /internet/msac/publishing.nsf/Content/1342.4-public 22129 407 1.616849168
MSAC - 1356 - Melanoma surveillance photography – total body photography and digital dermoscopy /internet/msac/publishing.nsf/Content/1356-public 23605 582 0.428861482
MSAC - 1372.1 MRI for patients with colorectal carcinoma (CRC) with suspected hepatic metastases or patients with suspected hepatocellular carcinoma (HCC) for the purposes of staging /internet/msac/publishing.nsf/Content/1372.1-public 23502 455 0.374058767
MSAC - 1376.1 - 70 gene signature (MammaPrint) for use in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit /internet/msac/publishing.nsf/Content/1376.1-public 22586 396 0.384931188
MSAC - 1399 - Percutaneous Tibial Nerve Stimulation administered through the Urgent PC Neuromodulation /internet/msac/publishing.nsf/Content/1399-public 24173 602 0.52801645
MSAC - 1407 - EGFR mutation testing to determine eligibility for access to PBS subsidised AZD9291 second line therapy in patients with locally advanced or metastatic NSCLC /internet/msac/publishing.nsf/Content/1407-public 23495 529 0.351335936
MSAC - 1411.1 - Genetic testing for hereditary mutations predisposing to cancer (breast and/or ovarian) (resubmission) /internet/msac/publishing.nsf/Content/1411.1-public 23139 410 0.600298776
MSAC - 1411 - Genetic testing for hereditary mutations predisposing to cancer (breast and/or ovarian) /internet/msac/publishing.nsf/Content/1411-public 21978 373 1.69250002
MSAC - 1420 - Extracorporeal photopheresis for treatment of acute and chronic graft-versus-host disease and cutaneous T-cell lymphoma /internet/msac/publishing.nsf/Content/1420-public 24065 541 0.390875574
MSAC - 1431 - HbA1c point of care test for the diagnosis and management of diabetes mellitus /internet/msac/publishing.nsf/Content/1431-public 23369 549 1.607985953
MSAC - 1435 - Processing and Cryopreservation of Male and Female Gonadal Tissue and Gametes Prior to or after Gonadotoxic Treatment to Preserve Fertility for the Future /internet/msac/publishing.nsf/Content/1435-public 23720 483 0.451196505
MSAC - 1439 - Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis /internet/msac/publishing.nsf/Content/1439-public 23034 475 0.338872475
MSAC - 1440 - PD-L1 testing for access to pembrolizumab in treatment na�ve patients with locally advanced or metastatic non-small cell lung cancer /internet/msac/publishing.nsf/Content/1440-public 22479 390 1.448496411
MSAC - 1454 - Diagnostic testing for ROS proto-oncogene 1 (ROS1) rearrangements in non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment /internet/msac/publishing.nsf/Content/1454-Public 22857 425 0.397531974
MSAC - 1455 - Proton Beam Therapy for patients supported under the Medical Treatment Overseas Program /internet/msac/publishing.nsf/Content/1455-public 23163 531 0.40835654
MSAC - 1464 - Breast Magnetic Resonance Imaging for improved definition of the breast cancer primary /internet/msac/publishing.nsf/Content/1464-public 22760 441 2.892945762
MSAC - 1466 - Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration /internet/msac/publishing.nsf/Content/1466-public 25171 665 0.621583014
MSAC - 1467 - Obstetric MRI /internet/msac/publishing.nsf/Content/1467-public 23015 445 1.049054392
MSAC - 1468 - SIR-Spheres for the treatment of hepatic metastases, and other indications not listed on the MBS /internet/msac/publishing.nsf/Content/1468-public 25539 661 1.221288466
MSAC - 1472– Cyanoacrylate embolisation for the treatment of varicose veins due to chronic venous insufficiency /internet/msac/publishing.nsf/Content/1472-public 22838 552 0.435852426
MSAC - 1473 - A 50 gene signature assay for predicting breast cancer recurrence /internet/msac/publishing.nsf/Content/1473-public 22945 501 0.37345086
MSAC - 1475 - Ablative fractional laser resurfacing for burn scar treatment /internet/msac/publishing.nsf/Content/1475-public 23575 590 1.338267875
MSAC - 1476 - Genetic testing for childhood syndromes /internet/msac/publishing.nsf/Content/1476-public 22336 451 0.357449654
MSAC - 1483 Micro-bypass stenting for open-angle glaucoma (in trabecular meshwork) /internet/msac/publishing.nsf/Content/1483-public 23448 573 0.354100258
MSAC - 1491 – Vagus nerve stimulation for chronic major depressive episodes /internet/msac/publishing.nsf/Content/1491-public 23851 639 0.3518374
MSAC - 1496 Micro-bypass stenting for open-angle glaucoma (external to Schlemm's canal) /internet/msac/publishing.nsf/Content/1496-public 23342 553 0.378206417
MSAC - 1498 - Serum soluble transferrin receptor /internet/msac/publishing.nsf/Content/1498-public 23232 568 0.334521361
MSAC - 1505 - Programmed cell death ligand 1 (PD L1) testing in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) to determine eligibility for durvalumab monotherapy or durvalumab/tremelimumab combination therapy (co dependent). /internet/msac/publishing.nsf/Content/1505-public 24136 670 0.559761658
MSAC - 1506 - Programmed cell death ligand 1 (PD-L1) testing to determine PBS access to durvalumab or durvalumab/tremelimumab as 1st line therapy for patients with unresectable Stage IV urothelial cancer /internet/msac/publishing.nsf/Content/1506-public 25030 768 0.366812559
MSAC - 1507 - Germline BRCA mutation testing to determine eligibility for olaparib treatment in patients with locally advanced or metastatic HER2 negative breast cancer (either hormone receptor positive or triple negative) /internet/msac/publishing.nsf/Content/1507-public 24088 751 0.34002561
MSAC - 1508 - Pembrolizumab (MK-3475) in Mismatch Repair Deficient (dMMR) Stage IV Solid tumours other than colorectal cancer /internet/msac/publishing.nsf/Content/1508-public 22148 403 0.359494717
MSAC - 1510 - Emicizumab for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with Haemophilia A (congenital Factor VIII deficiency) with Factor VIII inhibitors. /internet/msac/publishing.nsf/Content/1510-public 23768 614 0.353574289
MSAC - 1511 - Extended half-life (EHL) blood clotting factors VIII + IX /internet/msac/publishing.nsf/Content/1511-public 23564 611 0.434912037
MSAC - Sorry, we cannot find that page... /internet/msac/publishing.nsf/content/404ref.htm 20870 328 1.119654612
MSAC - About MSAC /internet/msac/publishing.nsf/Content/about-msac 23198 518 0.634414925
MSAC - Applicants /internet/msac/publishing.nsf/Content/applicants 26883 822 0.352047864
MSAC - Application Page /internet/msac/publishing.nsf/Content/application-page 104080 4784 0.943967556
MSAC - Assessment Group Guidelines and Templates /internet/msac/publishing.nsf/Content/assessment-groups 27366 860 0.428301095
MSAC - Combined Calendar /internet/msac/publishing.nsf/Content/combined-calendar 22803 496 0.386290002
/internet/msac/publishing.nsf/Content/D3E96917F7B2253BCA25801000123C2E/$File/1411.1_CUC-BreastOvarianCancerGeneticTesting.docx 132510 2246 0.352131327
/internet/msac/publishing.nsf/Content/D3E96917F7B2253BCA25801000123C2E/$File/1411.1_CUC-BreastOvarianCancerGeneticTesting.pdf 264201 0 0.329453344
/internet/msac/publishing.nsf/Content/D3E96917F7B2253BCA25801000123C2E/$File/1411.1_EconomicEvaluationReport.docx 852871 18932 0.289941565
/internet/msac/publishing.nsf/Content/D3E96917F7B2253BCA25801000123C2E/$File/1411.1_EconomicEvaluationReport.pdf 879682 0 0.169666969
/internet/msac/publishing.nsf/Content/D3E96917F7B2253BCA25801000123C2E/$File/PSD_1411.1.docx 417948 7551 0.328059226
/internet/msac/publishing.nsf/Content/D3E96917F7B2253BCA25801000123C2E/$File/PSD_1411.1.pdf 539779 0 0.323444774
MSAC - ESC Membership /internet/msac/publishing.nsf/Content/esc-membership 26572 366 0.474318652
MSAC - ESC Terms of Reference /internet/msac/publishing.nsf/Content/esc-terms-of-reference 24434 730 0.440526109
MSAC - Frequently Asked Questions and Factsheets /internet/msac/publishing.nsf/Content/frequently-asked-questions 25175 641 0.974899994
MSAC - Medical Services Advisory Committee /internet/msac/publishing.nsf/Content/Home-1 23948 369 0.51638442
MSAC - How to Apply for Public Funding /internet/msac/publishing.nsf/Content/how-to-apply-for-public-funding 23595 650 0.372618386
MSAC - MSAC Executive Terms of Reference /internet/msac/publishing.nsf/Content/msac-executive-terms-of-reference 23519 587 0.372704469
MSAC - MSAC Membership /internet/msac/publishing.nsf/Content/msac-membership 28996 401 0.516771376
MSAC - MSAC Process Framework /internet/msac/publishing.nsf/Content/msac-process-framework 22176 343 0.600986222
MSAC - MSAC Terms of Reference /internet/msac/publishing.nsf/Content/msac-terms-of-reference 25778 885 0.386963282
MSAC - PASC Membership /internet/msac/publishing.nsf/Content/pasc-membership 26508 362 0.458338785
MSAC - PASC Terms of Reference /internet/msac/publishing.nsf/Content/pasc-terms-of-reference 24086 675 0.368768821
MSAC - Predicted versus Actual Utilisation Monitoring Process /internet/msac/publishing.nsf/Content/Predicted-versus-Actual 24456 693 0.395864748